CA2184252C - Process for making monoacetals of hydroquinone - Google Patents
Process for making monoacetals of hydroquinoneInfo
- Publication number
- CA2184252C CA2184252C CA002184252A CA2184252A CA2184252C CA 2184252 C CA2184252 C CA 2184252C CA 002184252 A CA002184252 A CA 002184252A CA 2184252 A CA2184252 A CA 2184252A CA 2184252 C CA2184252 C CA 2184252C
- Authority
- CA
- Canada
- Prior art keywords
- process according
- ether
- hydroquinone
- group
- mixtures
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/30—Compounds having groups
- C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/48—Preparation of compounds having groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/48—Preparation of compounds having groups
- C07C41/50—Preparation of compounds having groups by reactions producing groups
- C07C41/54—Preparation of compounds having groups by reactions producing groups by addition of compounds to unsaturated carbon-to-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention is for a process for preparing monoacetals of hydroquinone wherein said process provides for higher yields of greater purity. Said process utilizes a two-step reaction wherein a protected hydroquinone is reacted with an enol ether to form a protected intermediate. Upon hydrogenolysis of said intermediate, a final product monoacetal hydroquinone, is formed having higher degree of purity and in greater yields than the yields attributed to reactions known in the art.
Description
f PROCESS FOR MAKING
MONOACETALS OF AYDROOUIrTONE
Field of the Invention The present invention is for a process for preparing monoacetals of hydroquinone wherein said process yields higher yields of greater purity than reactions previously used:
B~clcground of the Invention The process for making monoacetals of hydroquinone is disclosed in co-pending patent application U.S. Serial Number 081206,573, filed March 4, 1994;
incorporated herein by reference. Said process involves reacting equimolar amounts of hydroquinone with enol ethers in the presence of an acid catalyst:
pH
~ R O' 'n - ~~ .~.
.R ~
R ' R
I =_..
R
OR' R R
(i) each R is, independently, selected from the group consisting of hydrogen; C,- C,o alkyl; benzyl, aryl and substituted benzyl or aryl.
(ii) each R~ is, independently, selected from the group consisting of C,-C,o alkyl; benzyl, aryl and substituted benzyl or aryl.
. (iii) n is an integer from 0 to 3.
However, said reaction has several limitations. For equimolar concentrations of hydroquinone and enol ethers said reaction also results in formation of hydroquinone bis-acetals which are poor skin lightening compounds. Removal of the non-efficacious bis-acetal compounds, along with unreacted hydroquinone, necessitates expensive large scale chromatographic purification such that isolated yield of said monoacetal is poor, typically 30-40%. Attempts at improving overall yield and cost of process via conversion/recycling of bis-acetal to desired monoacetal is problematic due to similar reactivity of the two compounds, while changing the stoichiometry of the reaction to minimize bis-acetal formation increases the amount of hydroquinone which ultimately needs to be chromatographically removed.
Summary of the Invention The present invention is a process for preparing monoacetals of hydroquinone comprising the steps of (a) reacting monoethers of hydroquinone with an enol ether in the presence of an acid catalyst to yield the protected monoacetal of hydroquinone as an intermediate; and (b) reacting said intermediate with a hydrogen transfer source in the presence of a metal catalyst such that protecting group is selectively cleaved to give desired hydroquinone monoacetal.
These reactions produce purer hydroquinone monoacetals in high yield without the need for chromatographic purification.
Detailed Description of the Invention The present invention is a novel process for making hydroquinone monoacetals comprising a series of steps wherein monoethers of hydroquinone are used to improve the purity and the yield of the desired final product compared to the process previously disclosed.
Reaction of said hydroquinone monoether with an enol ether yields an intermediate product that is protected from acid catalyzed coupling with a second equivalent of enol ether, irrespective of the stoichiometry of the monoether compound and enol ether.
Utilization of protecting groups to eliminate production of undesirable by-products of synthesis reactions is well known in the art. In the present invention it is desirable to eliminate or at the very least minimize producing bis-acetal hydroquinone compounds, which if present at the time of the second process step of the present invention, yields undesirable final products. In the subsequent hydrogenolysis of said intermediate product, selective cleavage of ether protecting group provides the final desired product in higher yields with greater purity.
The hydroquinone protecting groups useful in the present invention are ethers susceptible to selective hydrogenolysis under mild conditions. Said ether used as protective groups in the present invention are selected from the group consisting of arylmethyl, diarylmethyl, triarylmethyl, trimethylsilyl ethers and mixtures thereof, preferably arylmethyl ethers. The preferred arylmethyl ether protecting groups of the present invention are selected from the group consisting of benzyl, aliphatic benzyl ethers and mixtures thereof, preferably aliphatic benzyl ether, most preferably the monobenzyl ether. The monobenzyl ether of hydroquinone may be purchased as monobenzone or 4-(benzyloxy)phenol directly from commercial sources such as Aldrich Chemical Company and Hoechst Celanese Corporation.
Monobenzone may also be produced by routine chemical reactions well known in the art; see Schiff and Pellizzari, Justus Liebi~'s Annalen Der Chimie. vol. 221, pp 370 (1883).
The said hydroquinone monoether is reacted with cyclic or acyclic enol ethers to yield the protected intermediate, preferably the benzyl protected monoacetal of hydroquinone, as illustrated below:
OHo go f I R O'C R H~ -~ I _ ~R
H
R i R R
OHo go R R' ~ . I .~... 0 1'i R . O OR' R' \
R R
Wherein: (i) each R is, independently, selected from the group consisting of hydrogen; Cl- Clo alkyl; benzyl, aryl and substituted benzyl or aryl, (ii) each R' is, independently, selected from the group consisting of C,-C,o alkyl; benzyl, aryl and substituted benzyl or aryl, (iii) n is an integer from 0 to 3; and (iv) Bn is a benzyl group.
This intermediate product is then subjected to a subsequent hydrogenolysis reaction in order to cleave said benzyl protective group from the intermediate product above to provide the final desired product. Selective removal of hydroxyl protecting groups including O-benzyl groups is known. Bieg and Szeja, Removal of O-Benzvl Protective Groups by Catalytic Transfer H~rdrogenation. Synthesis, January 1985, discloses the cleavage of benzyl ethers of monosaccharides using ammonium WO 95/23779 ~ PCT/US95/02738 formate as a hydrogen donor and 10% palladium on carbon catalyst. It is further disclosed therein that said method may be used for the selective removal of O-benzyl ethers in the presence of other types of O-protecting groups. Bieg and Szeja, Cleavage of 2-Phenyl-1 3-dioxolanes and Benzvl Ethers by Catalytic Transfer Hydrogenation, Synthesis, April 1986, discloses cleavage of 2-phenyl-1,3-dioxolane protective groups by catalytic transfer hydrogenation which circumvents the disadvantage of simultaneous cleavage of a 2-phenyl-1,3-dioxane group also present in the molecule. Hydrazine hydrate is used as the hydrogen source and 10%
palladium on carbon as the catalyst. Said reaction may be utilized for preparation of t0 a whole range of partially protected sugars.
In the present invention the hydrogenolysis step is as illustrated below:
OBn OH
Catalyst O O%R O O%R
R~Cn+2 R~Cn+2 R R R R
OBn OH
O OR' Catalyst O OR' R~ R~R
R R R
Cleavage of the benzyl group is accomplished in virtually quantitative yield with non-acidic hydrogen transfer sources such as hydrazine hydrate and ammonium formate in combination with a supported metal catalyst. The acetal portion of the intermediate molecule is unaffected by these conditions, eliminating the simultaneous formation of hydroquinone and/or regeneration of monobenzone. Hence there is no need for any chromatographic separation and the desired compounds can be isolated via simple purification techniques. Overall yield for the two step process is 2o significantly higher than the previously disclosed one step process.
MONOACETALS OF AYDROOUIrTONE
Field of the Invention The present invention is for a process for preparing monoacetals of hydroquinone wherein said process yields higher yields of greater purity than reactions previously used:
B~clcground of the Invention The process for making monoacetals of hydroquinone is disclosed in co-pending patent application U.S. Serial Number 081206,573, filed March 4, 1994;
incorporated herein by reference. Said process involves reacting equimolar amounts of hydroquinone with enol ethers in the presence of an acid catalyst:
pH
~ R O' 'n - ~~ .~.
.R ~
R ' R
I =_..
R
OR' R R
(i) each R is, independently, selected from the group consisting of hydrogen; C,- C,o alkyl; benzyl, aryl and substituted benzyl or aryl.
(ii) each R~ is, independently, selected from the group consisting of C,-C,o alkyl; benzyl, aryl and substituted benzyl or aryl.
. (iii) n is an integer from 0 to 3.
However, said reaction has several limitations. For equimolar concentrations of hydroquinone and enol ethers said reaction also results in formation of hydroquinone bis-acetals which are poor skin lightening compounds. Removal of the non-efficacious bis-acetal compounds, along with unreacted hydroquinone, necessitates expensive large scale chromatographic purification such that isolated yield of said monoacetal is poor, typically 30-40%. Attempts at improving overall yield and cost of process via conversion/recycling of bis-acetal to desired monoacetal is problematic due to similar reactivity of the two compounds, while changing the stoichiometry of the reaction to minimize bis-acetal formation increases the amount of hydroquinone which ultimately needs to be chromatographically removed.
Summary of the Invention The present invention is a process for preparing monoacetals of hydroquinone comprising the steps of (a) reacting monoethers of hydroquinone with an enol ether in the presence of an acid catalyst to yield the protected monoacetal of hydroquinone as an intermediate; and (b) reacting said intermediate with a hydrogen transfer source in the presence of a metal catalyst such that protecting group is selectively cleaved to give desired hydroquinone monoacetal.
These reactions produce purer hydroquinone monoacetals in high yield without the need for chromatographic purification.
Detailed Description of the Invention The present invention is a novel process for making hydroquinone monoacetals comprising a series of steps wherein monoethers of hydroquinone are used to improve the purity and the yield of the desired final product compared to the process previously disclosed.
Reaction of said hydroquinone monoether with an enol ether yields an intermediate product that is protected from acid catalyzed coupling with a second equivalent of enol ether, irrespective of the stoichiometry of the monoether compound and enol ether.
Utilization of protecting groups to eliminate production of undesirable by-products of synthesis reactions is well known in the art. In the present invention it is desirable to eliminate or at the very least minimize producing bis-acetal hydroquinone compounds, which if present at the time of the second process step of the present invention, yields undesirable final products. In the subsequent hydrogenolysis of said intermediate product, selective cleavage of ether protecting group provides the final desired product in higher yields with greater purity.
The hydroquinone protecting groups useful in the present invention are ethers susceptible to selective hydrogenolysis under mild conditions. Said ether used as protective groups in the present invention are selected from the group consisting of arylmethyl, diarylmethyl, triarylmethyl, trimethylsilyl ethers and mixtures thereof, preferably arylmethyl ethers. The preferred arylmethyl ether protecting groups of the present invention are selected from the group consisting of benzyl, aliphatic benzyl ethers and mixtures thereof, preferably aliphatic benzyl ether, most preferably the monobenzyl ether. The monobenzyl ether of hydroquinone may be purchased as monobenzone or 4-(benzyloxy)phenol directly from commercial sources such as Aldrich Chemical Company and Hoechst Celanese Corporation.
Monobenzone may also be produced by routine chemical reactions well known in the art; see Schiff and Pellizzari, Justus Liebi~'s Annalen Der Chimie. vol. 221, pp 370 (1883).
The said hydroquinone monoether is reacted with cyclic or acyclic enol ethers to yield the protected intermediate, preferably the benzyl protected monoacetal of hydroquinone, as illustrated below:
OHo go f I R O'C R H~ -~ I _ ~R
H
R i R R
OHo go R R' ~ . I .~... 0 1'i R . O OR' R' \
R R
Wherein: (i) each R is, independently, selected from the group consisting of hydrogen; Cl- Clo alkyl; benzyl, aryl and substituted benzyl or aryl, (ii) each R' is, independently, selected from the group consisting of C,-C,o alkyl; benzyl, aryl and substituted benzyl or aryl, (iii) n is an integer from 0 to 3; and (iv) Bn is a benzyl group.
This intermediate product is then subjected to a subsequent hydrogenolysis reaction in order to cleave said benzyl protective group from the intermediate product above to provide the final desired product. Selective removal of hydroxyl protecting groups including O-benzyl groups is known. Bieg and Szeja, Removal of O-Benzvl Protective Groups by Catalytic Transfer H~rdrogenation. Synthesis, January 1985, discloses the cleavage of benzyl ethers of monosaccharides using ammonium WO 95/23779 ~ PCT/US95/02738 formate as a hydrogen donor and 10% palladium on carbon catalyst. It is further disclosed therein that said method may be used for the selective removal of O-benzyl ethers in the presence of other types of O-protecting groups. Bieg and Szeja, Cleavage of 2-Phenyl-1 3-dioxolanes and Benzvl Ethers by Catalytic Transfer Hydrogenation, Synthesis, April 1986, discloses cleavage of 2-phenyl-1,3-dioxolane protective groups by catalytic transfer hydrogenation which circumvents the disadvantage of simultaneous cleavage of a 2-phenyl-1,3-dioxane group also present in the molecule. Hydrazine hydrate is used as the hydrogen source and 10%
palladium on carbon as the catalyst. Said reaction may be utilized for preparation of t0 a whole range of partially protected sugars.
In the present invention the hydrogenolysis step is as illustrated below:
OBn OH
Catalyst O O%R O O%R
R~Cn+2 R~Cn+2 R R R R
OBn OH
O OR' Catalyst O OR' R~ R~R
R R R
Cleavage of the benzyl group is accomplished in virtually quantitative yield with non-acidic hydrogen transfer sources such as hydrazine hydrate and ammonium formate in combination with a supported metal catalyst. The acetal portion of the intermediate molecule is unaffected by these conditions, eliminating the simultaneous formation of hydroquinone and/or regeneration of monobenzone. Hence there is no need for any chromatographic separation and the desired compounds can be isolated via simple purification techniques. Overall yield for the two step process is 2o significantly higher than the previously disclosed one step process.
2 ~ $ 4 2 5 L pcr~rs9sio~73s Reaction Method A. STEP ONE
As disclosed above the first step of the process is to produce the protected intermediate. In the case of the benzyl protecting group, 4-(benzyloxy)phenol is 5 combined with a cyclic or acyclic enol ether and a catalytic amount of acid under an inert atmosphere. In general, the stoichiometric ratio of enol ether and 4-(benzyloxy)phenol is from 1:1 to 2:1. A variety of acidic sources can be used, preferably those selected from the group consisting of hydrochloric acid, sulfuric acid, para-toluenesulfonic acid and mixtures thereof, wherein the catalytic dose does to not exceed 0.02 equivalents based on the weight of 4-(benzyloxy)phenol. A
typical dose is 0.005-0.015 equivalents of acid. Most preferred acidic source is hydrochloric acid.
Formation of the intermediate is conveniently carried out in a variety of polar organic solvents. Preferred polar solvents include those selected from the group consisting of methylene chloride, diethylether, tetrahydrofuran, dioxane and mixtures thereof, most preferred being methylene chloride. Typical total reactant concentrations are in the 5-15% weight range, although complete solvation of 4-(benzyloxy)phenol is not crucial.
Depending on the amount of starting materials, the intermediate forming 2o reaction takes from about 1 to about 16 hours at room temperature and atmospheric pressure. Changing the order of addition of starting materials has no affect on intermediate formation. In general, the reaction can be accelerated and forced to completion via the addition of fizrther quantities of enol ether. After solvent removal a series of washes and triturations with non-polar solvents, typically hexanes, allows purification of the intermediate in high yield, normally greater than about 80%. In the present invention a particular advantage of the use of 4-(benzyloxy)phenol is that large scale chromatographic purification is not required since any unreacted 4-(benzyloxy)phenol can be conveniently removed with an aqueous sodium hydroxide wash.
3o B. STEP TWO
Following the formation of said intermediate in step one, step two of the present process involves selective hydrogenolysis of the O-benzyl protecting group.
Said hydrogenolysis is accomplished by using any number of hydrogen donors. In the present invention it is preferred that the hydrogen transfer source is non-acidic and is selected from the group consisting of hydrazine, ammonium formate, trialkylammonium formates, and mixtures thereof; all readily available from commercial sources or which can be made prepared prior to reaction. Hydrazine is WO 95/23779 21 S 4 2 5 2 PCT~S95/02738 typically supplied in the hydrate form (55% w/w hydrazine) which can be used without further purification. The molar ratio of hydrogen transfer source to intermediate is from about 6:1 to about 1:1, preferably 4:1 to about 2:1, and most preferably 3:1.
Said hydrogenolysis also requires a supported metal catalyst, preferably a carbon supported metal selected from the group consisting of palladium, platinum, nickel and mixtures thereof. Most preferred is palladium on carbon. The weight percentage of metal in the supported catalyst is from about 2-20%, preferably S-10%.
to The reaction is carried out in an organic solvent which fully dissolves the intermediate upon refluxing. The preferred organic solvent is a hydroxy solvent, most preferred are those selected from the group consisting of methanol, ethanol, isopropanol and mixtures thereof, preferably methanol and ethanol.
Intermediate concentrations are typically in the 5-15% weight range relative to solvent.
Depending on the amount of starting materials, complete removal of benzyl group generally takes from about 0.5 to about 2.0 hours at reflux under an inert atmosphere. In the present invention a particular advantage of the use of non-acidic hydrogen transfer sources is that large scale chromatographic purification is not required since essentially no hydroquinone or monobenzone byproducts are formed.
2o The product is dried by solvent/water stripping and trituration with non-polar solvents or recrystallization from water/alcohol mixtures.
With regard to this second step involving reaction of the intermediate with said hydrogen donor, it is preferred that said intermediate is substantially free from impurities since they can negatively affect the reaction by, for example, modifying the surface of the preferred metal catalysts used herein.
EXAMPLE I
4-[(Tetrahydrofuran-2-yl)oxy]phenol is prepared as follows:
OH
O
O O
HCI NzH4.H20 CHzCl2 i ~ 5% Pd/C O
EtOH
O O
OH
STEP ONE:
3o Combine 4-(benzyloxy)phenol (34.0 g, 0.17 mol), concentrated hydrochloric acid (0.20 ml, 37%) and 300 ml of methylene chloride. Add to the resulting WO 95/23779 218 4 2 5 2 p~NS95102738 suspension drop by drop a solution of 2,3-dihydrofuran (22.8 g , 0.33 mol) and ml of methylene chloride. Stir the mixture at room temperature under an inert atmosphere for 16 hours at which time only trace amounts of 4-(benzyloxy)phenol remain by standard thin layer chromatography analysis (Vogel's Textbook of Practical Organic Chemistry, 5th Edition, p.199). Wash the reaction mixture with about three aliquots of 1N sodium hydroxide, each 300 ml, and back extract said aqueous washes with about 200 ml of methylene chloride. Combine the organic layers, dry over sodium sulfate, and concentrate in-vacuo to an oil.
Crystallize 2-[(4-benzyloxy)phenoxyJtetrahydrofuran from said oil via careful trituration with a non-1o polar solvent such as hexanes; melting point 43-44°C.
STEP TWO:
Add 55% hydrazine hydrate (1.8 g, 30.0 mmol) to a solution comprising 2-[(4-benzyloxy)phenoxy]tetrahydrofuran (2.7 g, 10.0 mmol), 5% Pd/C (0.4 g of 50%
wet material) and 50 ml of absolute ethanol. Heat reaction mixture at reflux under an >5 inert atmosphere for about 30 minutes. Cool the reaction mixture and filter off the catalyst. Concentrate the resulting clear pale yellow filtrate to an oil in-vacuo and co-distill in succession with two aliquots of ethanol (50 ml), two aliquots of ethyl acetate (SO ml) and two aliquots of hexanes (50 ml). Triturate the resulting solid with about 25 ml of hexane and dry in-vacuo at 40°C to constant weight.
2o Composition and purity of the cream colored 4-[tetrahydrofuran-2-yl)oxy]phenol is confirmed by IH and 13C NMR and elemental analysis; melting point 59-61°C.
EXAMPLE II
4-[(tetrahydro-2H-pyran-2-yl)oxy]phenol is prepared as follows:
OH
O
O O
HCI ~ NzH4.H20 CHZCIZ i 5% Pd/C O O
EtOH
O O
OH
25 STEP ONE:
Slowly add, under an inert atmosphere, a methylene chloride solution of 3,4-dihydro-2H-pyran (37.3 g, 0.44 mol) to a solution comprising 4-(benzyloxy)phenol (88.8 g, 0.44 mol), concentrated hydrochloric acid (0.25 ml, 37%) and 600 ml of methylene chloride. This reaction mixture is stirred at room temperature for about 30 15 minutes, at which time a substantial amount of 4-(benzyloxy)phenol is present by WO 95/23779 2 ~ g 4 2 5 2 pCT~S95/02738 th;n layer chromatography. Add to the reaction mixture two consecutive portions of a solution comprising 3,4-dihydro-2H-pyran (7.5 g) and 25 ml of methylene chloride.
Stir the mixture for about 1 hour wherein only trace amounts of starting phenol remain.
Wash the reaction mixture with about three aliquots of 4% aqueous sodium hydroxide, each 400 ml. Separate the aqueous layer and back extract said layer with about 100 ml of methylene chloride. Combine the organic layers, dry over sodium sulfate, and concentrate in vacuo at about 40°C to a volume of about 200 ml.
Remove excess methylene chloride by co-distilling said concentrate with a sufficient 1o amount of hexane to bring the total volume of the distillate to about 250 ml. Dilute the resulting white suspension with hexane and cool said mixture to about ambient temperature. Collect the precipitated intermediate, 2-[(4 benzyloxy)phenoxy]tetrahydropyran, on a filter and wash in-situ with 100 ml aliquots of hexane. Dry said precipitate in vacuo at about 35°C until a constant weight is obtained; melting point 70-71°C.
STEP TWO:
Add 55% hydrazine hydrate (34.85 . g, 0.6 mol) to a stirred suspension comprising 2-[(4-benzyloxy)phenoxy]tetrahydropyran (56.4 g, 0.2 mol), 5% Pd/C
(4.1 g of 50% wet material) and about 450 ml of absolute ethanol. Slowly heat the 2o reaction mixture and maintain at reflux under an inert atmosphere until thin layer chromatography analysis indicates complete consumption of 2-((4-benzyloxy)phenoxy]tetrahydropyran. Cool the reaction mixture to about 50°C, clarify said mixture by filtration, and concentrate to a solid in-vacuo at 40°C.
Suspend said solid in ethanol and slowly dilute said suspension with de-ionized water. Stir for about 30 minutes and collect the white solid on a filter. Wash said solid in-situ with water, then re-suspend the solid in water. Re-collect the solid, wash in-situ with water and dry in-vacuo at 24°C to constant weight.
Further purification of 4-[(tetrahydro-2H-pyran-2-yl)oxy]phenol, if necessary, is achieved by a second round of recrystallization from aqueous ethanol.
3o Composition and purity is confirmed by 1H and 13C NMR and elemental analysis;
melting point 86-87°C
EXAMPLE III
4-((1-butoxyethyl)oxy]phenol is prepared as follows:
W0 95123779 218 4 2 5 ~ p~~s95/02738 OH
O
O 'O
H~ NZH4.H20 CH~CI~ 5% Pd/C O"O
MeO IYH
O"O
O ~I'H
STEP ONE:
In similar fashion to Examples I and II, slowly add a methylene chloride solution of butyl vinyl ether (6.2 g, 0.06 mol) to a solution comprising 4 (benzyloxy)phenol (12.4 g, 0.06 mol), concentrated hydrochloric acid (0.15 ml, 37 % ) and 100 ml of methylene chloride. Stir under an inert atmosphere for about 2 hours and analyze reaction mixture for 4-(benzyloxy)phenol by thin layer chromatography. If 4-(benzyloxy)phenol is still present, add to said reaction mixture a further portion of butyl vinyl ether (1.8 g, 0.02 mol) in 25 ml of io methylene chloride and continue to stir until the phenol is consumed.
Wash the reaction mixture with about three aliquots of 1 N sodium hydroxide, each 250 ml, and back extract said aqueous washes with about 100 ml of methylene chloride. Combine the organic layers, dry over sodium sulfate, and concentrate benzyl protected intermediate in-vacuo to a pale yellow oil.
~5 Composition and purity of intermediate is confirmed by 1H and 13C NMR.
STEP TWO:
Add 55 % hydrazine hydrate (2.5 g, 0.078 mol) to a stirred suspension comprising intermediate from step one (5.0 g, 0.017 mol), S % Pd/C (3.8 g) and about 100 ml of methanol. Heat the reaction mixture and maintain at reflux under 2o an inert atmosphere for about 2 hours whereupon thin layer chromatography analysis indicates complete consumption of the benzyl protected intermediate.
Cool the reaction mixture to room temperature and filter off the catalyst.
Concentrate the resulting clear pale yellow filtrate to an oil in-vacuo, wash with hexanes and dry to constant weight in-vacuo at 50°C. Composition and purity of 2s isolated 4-[(1-butoxyethyl)oxy]phenol is confirmed by 1H and 13C NMR.
As disclosed above the first step of the process is to produce the protected intermediate. In the case of the benzyl protecting group, 4-(benzyloxy)phenol is 5 combined with a cyclic or acyclic enol ether and a catalytic amount of acid under an inert atmosphere. In general, the stoichiometric ratio of enol ether and 4-(benzyloxy)phenol is from 1:1 to 2:1. A variety of acidic sources can be used, preferably those selected from the group consisting of hydrochloric acid, sulfuric acid, para-toluenesulfonic acid and mixtures thereof, wherein the catalytic dose does to not exceed 0.02 equivalents based on the weight of 4-(benzyloxy)phenol. A
typical dose is 0.005-0.015 equivalents of acid. Most preferred acidic source is hydrochloric acid.
Formation of the intermediate is conveniently carried out in a variety of polar organic solvents. Preferred polar solvents include those selected from the group consisting of methylene chloride, diethylether, tetrahydrofuran, dioxane and mixtures thereof, most preferred being methylene chloride. Typical total reactant concentrations are in the 5-15% weight range, although complete solvation of 4-(benzyloxy)phenol is not crucial.
Depending on the amount of starting materials, the intermediate forming 2o reaction takes from about 1 to about 16 hours at room temperature and atmospheric pressure. Changing the order of addition of starting materials has no affect on intermediate formation. In general, the reaction can be accelerated and forced to completion via the addition of fizrther quantities of enol ether. After solvent removal a series of washes and triturations with non-polar solvents, typically hexanes, allows purification of the intermediate in high yield, normally greater than about 80%. In the present invention a particular advantage of the use of 4-(benzyloxy)phenol is that large scale chromatographic purification is not required since any unreacted 4-(benzyloxy)phenol can be conveniently removed with an aqueous sodium hydroxide wash.
3o B. STEP TWO
Following the formation of said intermediate in step one, step two of the present process involves selective hydrogenolysis of the O-benzyl protecting group.
Said hydrogenolysis is accomplished by using any number of hydrogen donors. In the present invention it is preferred that the hydrogen transfer source is non-acidic and is selected from the group consisting of hydrazine, ammonium formate, trialkylammonium formates, and mixtures thereof; all readily available from commercial sources or which can be made prepared prior to reaction. Hydrazine is WO 95/23779 21 S 4 2 5 2 PCT~S95/02738 typically supplied in the hydrate form (55% w/w hydrazine) which can be used without further purification. The molar ratio of hydrogen transfer source to intermediate is from about 6:1 to about 1:1, preferably 4:1 to about 2:1, and most preferably 3:1.
Said hydrogenolysis also requires a supported metal catalyst, preferably a carbon supported metal selected from the group consisting of palladium, platinum, nickel and mixtures thereof. Most preferred is palladium on carbon. The weight percentage of metal in the supported catalyst is from about 2-20%, preferably S-10%.
to The reaction is carried out in an organic solvent which fully dissolves the intermediate upon refluxing. The preferred organic solvent is a hydroxy solvent, most preferred are those selected from the group consisting of methanol, ethanol, isopropanol and mixtures thereof, preferably methanol and ethanol.
Intermediate concentrations are typically in the 5-15% weight range relative to solvent.
Depending on the amount of starting materials, complete removal of benzyl group generally takes from about 0.5 to about 2.0 hours at reflux under an inert atmosphere. In the present invention a particular advantage of the use of non-acidic hydrogen transfer sources is that large scale chromatographic purification is not required since essentially no hydroquinone or monobenzone byproducts are formed.
2o The product is dried by solvent/water stripping and trituration with non-polar solvents or recrystallization from water/alcohol mixtures.
With regard to this second step involving reaction of the intermediate with said hydrogen donor, it is preferred that said intermediate is substantially free from impurities since they can negatively affect the reaction by, for example, modifying the surface of the preferred metal catalysts used herein.
EXAMPLE I
4-[(Tetrahydrofuran-2-yl)oxy]phenol is prepared as follows:
OH
O
O O
HCI NzH4.H20 CHzCl2 i ~ 5% Pd/C O
EtOH
O O
OH
STEP ONE:
3o Combine 4-(benzyloxy)phenol (34.0 g, 0.17 mol), concentrated hydrochloric acid (0.20 ml, 37%) and 300 ml of methylene chloride. Add to the resulting WO 95/23779 218 4 2 5 2 p~NS95102738 suspension drop by drop a solution of 2,3-dihydrofuran (22.8 g , 0.33 mol) and ml of methylene chloride. Stir the mixture at room temperature under an inert atmosphere for 16 hours at which time only trace amounts of 4-(benzyloxy)phenol remain by standard thin layer chromatography analysis (Vogel's Textbook of Practical Organic Chemistry, 5th Edition, p.199). Wash the reaction mixture with about three aliquots of 1N sodium hydroxide, each 300 ml, and back extract said aqueous washes with about 200 ml of methylene chloride. Combine the organic layers, dry over sodium sulfate, and concentrate in-vacuo to an oil.
Crystallize 2-[(4-benzyloxy)phenoxyJtetrahydrofuran from said oil via careful trituration with a non-1o polar solvent such as hexanes; melting point 43-44°C.
STEP TWO:
Add 55% hydrazine hydrate (1.8 g, 30.0 mmol) to a solution comprising 2-[(4-benzyloxy)phenoxy]tetrahydrofuran (2.7 g, 10.0 mmol), 5% Pd/C (0.4 g of 50%
wet material) and 50 ml of absolute ethanol. Heat reaction mixture at reflux under an >5 inert atmosphere for about 30 minutes. Cool the reaction mixture and filter off the catalyst. Concentrate the resulting clear pale yellow filtrate to an oil in-vacuo and co-distill in succession with two aliquots of ethanol (50 ml), two aliquots of ethyl acetate (SO ml) and two aliquots of hexanes (50 ml). Triturate the resulting solid with about 25 ml of hexane and dry in-vacuo at 40°C to constant weight.
2o Composition and purity of the cream colored 4-[tetrahydrofuran-2-yl)oxy]phenol is confirmed by IH and 13C NMR and elemental analysis; melting point 59-61°C.
EXAMPLE II
4-[(tetrahydro-2H-pyran-2-yl)oxy]phenol is prepared as follows:
OH
O
O O
HCI ~ NzH4.H20 CHZCIZ i 5% Pd/C O O
EtOH
O O
OH
25 STEP ONE:
Slowly add, under an inert atmosphere, a methylene chloride solution of 3,4-dihydro-2H-pyran (37.3 g, 0.44 mol) to a solution comprising 4-(benzyloxy)phenol (88.8 g, 0.44 mol), concentrated hydrochloric acid (0.25 ml, 37%) and 600 ml of methylene chloride. This reaction mixture is stirred at room temperature for about 30 15 minutes, at which time a substantial amount of 4-(benzyloxy)phenol is present by WO 95/23779 2 ~ g 4 2 5 2 pCT~S95/02738 th;n layer chromatography. Add to the reaction mixture two consecutive portions of a solution comprising 3,4-dihydro-2H-pyran (7.5 g) and 25 ml of methylene chloride.
Stir the mixture for about 1 hour wherein only trace amounts of starting phenol remain.
Wash the reaction mixture with about three aliquots of 4% aqueous sodium hydroxide, each 400 ml. Separate the aqueous layer and back extract said layer with about 100 ml of methylene chloride. Combine the organic layers, dry over sodium sulfate, and concentrate in vacuo at about 40°C to a volume of about 200 ml.
Remove excess methylene chloride by co-distilling said concentrate with a sufficient 1o amount of hexane to bring the total volume of the distillate to about 250 ml. Dilute the resulting white suspension with hexane and cool said mixture to about ambient temperature. Collect the precipitated intermediate, 2-[(4 benzyloxy)phenoxy]tetrahydropyran, on a filter and wash in-situ with 100 ml aliquots of hexane. Dry said precipitate in vacuo at about 35°C until a constant weight is obtained; melting point 70-71°C.
STEP TWO:
Add 55% hydrazine hydrate (34.85 . g, 0.6 mol) to a stirred suspension comprising 2-[(4-benzyloxy)phenoxy]tetrahydropyran (56.4 g, 0.2 mol), 5% Pd/C
(4.1 g of 50% wet material) and about 450 ml of absolute ethanol. Slowly heat the 2o reaction mixture and maintain at reflux under an inert atmosphere until thin layer chromatography analysis indicates complete consumption of 2-((4-benzyloxy)phenoxy]tetrahydropyran. Cool the reaction mixture to about 50°C, clarify said mixture by filtration, and concentrate to a solid in-vacuo at 40°C.
Suspend said solid in ethanol and slowly dilute said suspension with de-ionized water. Stir for about 30 minutes and collect the white solid on a filter. Wash said solid in-situ with water, then re-suspend the solid in water. Re-collect the solid, wash in-situ with water and dry in-vacuo at 24°C to constant weight.
Further purification of 4-[(tetrahydro-2H-pyran-2-yl)oxy]phenol, if necessary, is achieved by a second round of recrystallization from aqueous ethanol.
3o Composition and purity is confirmed by 1H and 13C NMR and elemental analysis;
melting point 86-87°C
EXAMPLE III
4-((1-butoxyethyl)oxy]phenol is prepared as follows:
W0 95123779 218 4 2 5 ~ p~~s95/02738 OH
O
O 'O
H~ NZH4.H20 CH~CI~ 5% Pd/C O"O
MeO IYH
O"O
O ~I'H
STEP ONE:
In similar fashion to Examples I and II, slowly add a methylene chloride solution of butyl vinyl ether (6.2 g, 0.06 mol) to a solution comprising 4 (benzyloxy)phenol (12.4 g, 0.06 mol), concentrated hydrochloric acid (0.15 ml, 37 % ) and 100 ml of methylene chloride. Stir under an inert atmosphere for about 2 hours and analyze reaction mixture for 4-(benzyloxy)phenol by thin layer chromatography. If 4-(benzyloxy)phenol is still present, add to said reaction mixture a further portion of butyl vinyl ether (1.8 g, 0.02 mol) in 25 ml of io methylene chloride and continue to stir until the phenol is consumed.
Wash the reaction mixture with about three aliquots of 1 N sodium hydroxide, each 250 ml, and back extract said aqueous washes with about 100 ml of methylene chloride. Combine the organic layers, dry over sodium sulfate, and concentrate benzyl protected intermediate in-vacuo to a pale yellow oil.
~5 Composition and purity of intermediate is confirmed by 1H and 13C NMR.
STEP TWO:
Add 55 % hydrazine hydrate (2.5 g, 0.078 mol) to a stirred suspension comprising intermediate from step one (5.0 g, 0.017 mol), S % Pd/C (3.8 g) and about 100 ml of methanol. Heat the reaction mixture and maintain at reflux under 2o an inert atmosphere for about 2 hours whereupon thin layer chromatography analysis indicates complete consumption of the benzyl protected intermediate.
Cool the reaction mixture to room temperature and filter off the catalyst.
Concentrate the resulting clear pale yellow filtrate to an oil in-vacuo, wash with hexanes and dry to constant weight in-vacuo at 50°C. Composition and purity of 2s isolated 4-[(1-butoxyethyl)oxy]phenol is confirmed by 1H and 13C NMR.
Claims (16)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for preparing monoacetals of hydroquinone comprising the steps of:
(a) reacting monoether of hydroquinone with an enol ether in the presence of an acid catalyst to yield an intermediate monoacetal of hydroquinone that is protected by an ether protecting group; and (b) reacting said intermediate with a non-acidic hydrogen transfer source selected from the group consisting of hydrazine, ammonium formate, trialkylammonium formates, and mixtures thereof, in a molar ratio of hydrogen transfer source to intermediate from about 6:1 to about 1:1, in the presence of a metal catalyst such that the ether protecting group is selectively cleaved to give the desired hydroquinone monoacetal.
(a) reacting monoether of hydroquinone with an enol ether in the presence of an acid catalyst to yield an intermediate monoacetal of hydroquinone that is protected by an ether protecting group; and (b) reacting said intermediate with a non-acidic hydrogen transfer source selected from the group consisting of hydrazine, ammonium formate, trialkylammonium formates, and mixtures thereof, in a molar ratio of hydrogen transfer source to intermediate from about 6:1 to about 1:1, in the presence of a metal catalyst such that the ether protecting group is selectively cleaved to give the desired hydroquinone monoacetal.
2. The process according to claim 1 wherein the ether protecting group is selected from the group consisting of arylmethyl, diarylmethyl, triarylmethyl, trimethylsilyl ethers and mixtures thereof.
3. The process according to claim 2 wherein the ether protecting group is an arylmethyl ether.
4. The process according to claim 3 wherein the arylmethyl ether is selected from the group consisting of benzyl ethers, aliphatic benzyl ethers and mixtures thereof.
5. The process according to claim 4 wherein the arylmethyl ether is an aliphatic benzyl ether or benzyl ether.
6. The process according to claim 5 wherein the arylmethyl ether is benzyl ether.
7. The process according to claim 1 wherein the hydrogen transfer source is hydrazine in a molar ratio of hydrazine to intermediate product of about 4:1 to about 2:1.
8. The process according to claim 1 wherein the formation of the intermediate is carried out in a polar organic solvent.
9. The process according to claim 8 wherein the polar organic solvent is selected from the group consisting of methylene chloride, diethylether, tetrahydrofuran, dioxane and mixtures thereof.
10. The process according to claim 9 wherein the polar organic solvent is methylene chloride.
11. The process according to claim 1 wherein the metal catalyst is a carbon supported metal selected from the group consisting of palladium, platinum, nickel and mixtures thereof, wherein the weight percentage of metal in the supported catalyst is from about 2-20%.
12. The process according to claim 11 wherein the metal catalyst is palladium on carbon.
13. The process according to claim 11 wherein the reaction of the intermediate and the hydrogen transfer source is carried out in a polar organic solvent.
14. The process according to claim 13 wherein the polar organic solvent is a hydroxy solvent.
15. The process according to claim 14 wherein the hydroxy solvent is selected from the group consisting of methanol, ethanol, isopropanol and mixtures thereof.
16. The process according to claim 15 wherein the hydroxy solvent is methanol or ethanol.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20657394A | 1994-03-04 | 1994-03-04 | |
US08/206,573 | 1994-12-16 | ||
US08/357,849 US5585525A (en) | 1994-12-16 | 1994-12-16 | Process for making monoacetals of hydroquinone |
US08/357,849 | 1994-12-16 | ||
PCT/US1995/002738 WO1995023779A2 (en) | 1994-03-04 | 1995-03-03 | Process for making monoacetals of hydroquinone |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2184252A1 CA2184252A1 (en) | 1995-09-08 |
CA2184252C true CA2184252C (en) | 1999-12-07 |
Family
ID=26901478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002184252A Expired - Fee Related CA2184252C (en) | 1994-03-04 | 1995-03-03 | Process for making monoacetals of hydroquinone |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0748306A1 (en) |
JP (1) | JPH09509946A (en) |
KR (1) | KR970701684A (en) |
CN (1) | CN1145616A (en) |
AU (2) | AU1932295A (en) |
CA (1) | CA2184252C (en) |
CZ (1) | CZ257096A3 (en) |
WO (2) | WO1995023778A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU715783B2 (en) * | 1994-03-04 | 2000-02-10 | Procter & Gamble Company, The | Process for making monoacetals of hydroquinone |
KR100453590B1 (en) * | 2001-10-17 | 2004-10-20 | 주식회사 바이오랜드 | Mono carbonylation of Benzene diols |
JP4632077B2 (en) * | 2002-10-15 | 2011-02-16 | Dic株式会社 | Epoxy resin composition, method for producing epoxy resin, novel epoxy resin, and novel phenol resin |
BRPI0612126A2 (en) * | 2005-06-16 | 2011-01-04 | Girindus Ag | method for synthesizing a compound |
SE535691C2 (en) | 2011-03-08 | 2012-11-13 | Kat2Biz Ab | Reduction of C-O bonds via catalytic transfer hydrogenolysis |
JP5817614B2 (en) * | 2012-03-26 | 2015-11-18 | 日本ゼオン株式会社 | Method for producing 2,5-dihydroxybenzaldehyde compound |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR204334A1 (en) * | 1973-01-17 | 1975-12-22 | Ciba Geigy Ag | PROCEDURE FOR THE PREPARATION OF 1- (4- (ALKYLTIO-ALCOXY) -PHENOXY) -2-HYDROXY-3-ALKYL-AMINO-PROPAN COMPOUNDS |
-
1995
- 1995-02-27 AU AU19322/95A patent/AU1932295A/en not_active Withdrawn
- 1995-02-27 WO PCT/US1995/002382 patent/WO1995023778A2/en active Application Filing
- 1995-03-03 EP EP95912054A patent/EP0748306A1/en not_active Ceased
- 1995-03-03 WO PCT/US1995/002738 patent/WO1995023779A2/en not_active Application Discontinuation
- 1995-03-03 AU AU19395/95A patent/AU1939595A/en not_active Abandoned
- 1995-03-03 KR KR1019960704856A patent/KR970701684A/en not_active Application Discontinuation
- 1995-03-03 JP JP7523070A patent/JPH09509946A/en active Pending
- 1995-03-03 CN CN95192503A patent/CN1145616A/en active Pending
- 1995-03-03 CA CA002184252A patent/CA2184252C/en not_active Expired - Fee Related
- 1995-03-03 CZ CZ962570A patent/CZ257096A3/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU1932295A (en) | 1995-09-18 |
CN1145616A (en) | 1997-03-19 |
WO1995023779A2 (en) | 1995-09-08 |
WO1995023778A3 (en) | 1995-09-28 |
AU1939595A (en) | 1995-09-18 |
WO1995023779A3 (en) | 1995-09-28 |
MX9603877A (en) | 1997-09-30 |
WO1995023778A2 (en) | 1995-09-08 |
EP0748306A1 (en) | 1996-12-18 |
CA2184252A1 (en) | 1995-09-08 |
KR970701684A (en) | 1997-04-12 |
CZ257096A3 (en) | 1997-06-11 |
JPH09509946A (en) | 1997-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU198437B (en) | Process for producing mono- or bis-carbonyl-compounds | |
SU795451A3 (en) | Method of preparing neopentylglycol | |
EP0000092B1 (en) | Method of preparing ascorbic acid and intermediates specially adapted for use therein | |
CA2184252C (en) | Process for making monoacetals of hydroquinone | |
KR20060132860A (en) | Methods for preparing 1,3-butylene glycol | |
US5585525A (en) | Process for making monoacetals of hydroquinone | |
CA1319707C (en) | Process for the preparation of serinol | |
AU715783B2 (en) | Process for making monoacetals of hydroquinone | |
Scolastico et al. | Diastereo-and enantioselective synthesis of fluorinated threonines | |
Burton et al. | 621. Branched-chain sugars. Part III. The introduction of branching into methyl 3, 4-O-isopropylidene-β-L-arabinoside and the synthesis of L-hamamelose | |
Mandai et al. | The palladium-catalyzed reactions of 2-alkynyl carbonates with terminal acetylenes. A new synthetic method for 1, 2-dien-4-ynes | |
Pougny et al. | A synthesis of the marine antibiotic (-)-malyngolide from D-glucose | |
MXPA96003877A (en) | Procedure for developing monoacetals dehydroquin | |
AU570484B2 (en) | Preparation of cyanohydrins | |
Reese | Facile preparation of acetals and enol ethers derived from 1-arylpiperidin-4-ones | |
Massing et al. | New optically pure dimethylacetals of glyceraldehydes and their application for lipid and phospholipid synthesis | |
JP2675156B2 (en) | Process for producing 1,1,2-trialkoxyethane | |
US4734506A (en) | 4-amino-3-imidazolin-2-one | |
US4361702A (en) | Process for the preparation of trans-3-formylbut-2-enenitrile | |
Tsukayama et al. | Regioselective synthesis of prenylisoflavones. Syntheses of allolicoisoflavone A, 2, 3-dehydrokievitone, and related compounds | |
GB1574561A (en) | Process d.for the preparation of cylohexanedione diketals | |
JP3598421B2 (en) | Method for producing 2-substituted-1,3-propanediol | |
Sheehan et al. | α-Lactams. III. The Reaction of 1-t-Butyl-3, 3-dimethylaziridinone with Lithium Aluminum Hydride | |
US4374069A (en) | Process for the preparation of trans-3-formylbut-2-enenitrile | |
JP3227020B2 (en) | Ketals and their production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |